Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Na-Phenylbutyrate VAscular Trial
NCT06645769Phase 1Not yet recruiting
- Sponsor
- University of Pennsylvania
- Start
- Jun 2027
- Primary completion
- Jan 2028
- Modality
- Small Molecules
01
Overview
Phase 1, randomised trial in diabetes mellitus (DM) comparing NaPB administration with Placebo control (2 arms). Primary endpoint: Systemic vascular resistance at 8 weeks. Planned start Jun 2027; status: not yet recruiting.
02
Drugs
sodium phenylbutyrate
03
Conditions
diabetes mellitus (DM)
Beyond the preview
Go deeper on NCT06645769.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06645769.